HS Code 3004900000 80 Other

Import trade restrictions for 3004900000 80

This table contains information on trade restrictions for the import of goods into the EU and the EU into third countries. The table contains information on trade restrictions which are imposed due to customs unions, preferences, tariff quotas, customs unions, veterinary controls, third country duties and non-preferential tariff quotas.

Duties 22
	Origin country	Start	Duty / Tax	Legal base Measure type
1011	ERGA OMNES 1011	01-01-2002	0 %	Regulation2031/01 Third country duty 103
FO	Faroe Islands FO	01-01-1997	0 %	Decision0126/97 Tariff preference 142
XL	Melilla XL	01-01-1999	0 %	Accession act0001/85 Tariff preference 142
SM	San Marino SM	01-01-2006	0 %	Decision0245/02 Customs union duty 106
TR	Türkiye TR	01-01-2006	0 %	Decision0142/96 Customs union duty 106
AD	Andorra AD	01-01-2006	0 %	Decision0680/90 Customs union duty 106
1007	EU-Switzerland agreement: re-imported goods 1007	01-01-2007	0 %	Regulation2840/72 Tariff preference 142
GB	United Kingdom GB	01-01-2021	0 %	Decision2253/20 Tariff preference 142
2080	OCTs (Overseas Countries and Territories) 2080	01-01-2021	0 %	Decision1764/21 Tariff preference 142
TN	Tunisia TN	01-03-1998	0 %	Decision0238/98 Tariff preference 142
MA	Morocco MA	01-03-2000	0 %	Decision0204/00 Tariff preference 142
LB	Lebanon LB	01-04-2006	0 %	Decision0356/06 Tariff preference 142
JO	Jordan JO	01-05-2002	0 %	Decision0357/02 Tariff preference 142
XC	Ceuta XC	01-07-1991	0 %	Accession act0001/85 Tariff preference 142
US	United States US	01-07-2026	0 %	Regulation1455/26 Tariff preference 142
SY	Syria SY	01-08-1994	0 %	Regulation2216/78 Tariff preference 142
DZ	Algeria DZ	01-09-2005	0 %	Decision0690/05 Tariff preference 142
1011	ERGA OMNES 1011	01-11-2026	2 EUR	Regulation2108/26 Union handling fee 800
1011	ERGA OMNES 1011	01-11-2026	3 EUR	Regulation0382/26 Low-value consignment customs duty 107
2000	Preferential origin in accordance with the Agreement in the form of an Exchange of Letters between the European Union and the Kingdom of Morocco on the amendment of Protocols 1 and 4 to the Euro-Mediterranean Agreement establishing an association between the European Communities and their Member States, of the one part, and the Kingdom of Morocco, of the other part. 2000	03-10-2025	0 %	Decision2022/25 Tariff preference 142
IL	Israel IL	16-05-2023	0 %	Decision0855/09 Tariff preference 142
CH	Switzerland CH	25-10-2000	0 %	Regulation2840/72 Tariff preference 142

Controls and documents 6
	Origin country	Start	Duty / Tax	Legal base Measure type
1011	ERGA OMNES 1011	17-09-2025	Document required banned without it	Regulation0573/24 Import control of fluorinated greenhouse gases 724
1011	ERGA OMNES 1011	18-10-2015	Document required banned without it	Regulation1850/15 Import control on seal products 746
1011	ERGA OMNES 1011	20-05-2023	Document required banned without it	Regulation0966/23 Import control - CITES 710
1011	ERGA OMNES 1011	10-02-2023	Document required banned without it	Regulation1907/06 Import control on REACH 761
UA	Ukraine UA	24-06-2026	Document required banned without it	Regulation0263/22 Import control 762
UA	Ukraine UA	24-06-2026	Document required banned without it	Regulation0692/14 Import control 760

Explanation of trade restrictions

Erga Omnes means "for all".

Third countries are countries that are not part of the EU.

GSP means "Generalised System of Preferences".

GSP Plus means "Generalised System of Preferences Plus".

European Economic Area (EEA) means all EU member states and Iceland, Liechtenstein and Norway.

OCTs stands for "Overseas Countries and Territories". They are countries and territories that are not part of the EU. More information

CARIFORUM is a regional economic integration organisation comprising 15 Caribbean Community (CARICOM) countries and the Dominican Republic.

SADC EPA stands for "Southern African Development Community - Economic Partnership Agreement".

Duty means "customs duties".

Estimate the import cost for 300490

Customs value Currency

Country of origin Imported into With proof of preferential origin (0 %) Sold online to a buyer in the EU (distance sale)

Customs value €1,000.00
Customs duty 0 % €0.00
Import VAT 19 % €190.00
Total €1,190.00

Documents and checks for Switzerland

Import control of fluorinated greenhouse gases: Document required, banned without it Y123 Y160 Y162 C057 C079 C082 Y120 Y179 Y166 Y163 Y121
Import control on seal products: Document required, banned without it C679 C680 C683 Y032
Import control - CITES: Document required, banned without it C400 Y900
Import control on REACH: Document required, banned without it Y106 Y110 Y113

An estimate only. The customs value is the price including transport and insurance to the EU border. Excise duties, other fees and producer-specific anti-dumping rates are not included. Preferential rates need valid proof of origin. Country groups and exclusions: TARIC, as of November 2026.

Export measures for 3004900000

What applies when these goods leave the EU: export controls, dual-use and other authorisations, bans per destination and the supplementary unit of the export declaration.

Controls and documents 4
	Destination	Start	Duty / Tax	Legal base Measure type
3500	Territories not included in the customs territory 3500	20-02-2019	Document required banned without it	Regulation0125/19 Goods for torture and repression, export restriction 708
1008	All third countries 1008	20-02-2019	Document required banned without it	Regulation0125/19 Goods for torture and repression, export restriction 708
1008	All third countries 1008	20-05-2023	Document required banned without it	Regulation0966/23 Export control - CITES 715
1008	All third countries 1008	31-01-2025	Document required banned without it	Regulation0573/24 Export control of fluorinated greenhouse gases 765

History

Duty rates and measures for this code over time (yearly snapshots).

Preferential rules of origin for 3004900000

What the goods must meet to count as originating in a partner country and get the preferential duty, per agreement.

EU-Algeria Association Agreement · Algeria
EU-Egypt Association Agreement · Egypt
EU-Morocco Association Agreement · Morocco

Medicaments (excluding goods of heading 3002, 3005 or 3006):
– Obtained from amikacin of heading 2941 / or: Manufacture from materials of any heading, except that of the product. However, materials of headings 3003 and 3004 may be used, provided that their total value does not exceed 20 % of the ex-works price of the product
– Other / or: Manufacture: from materials of any heading, except that of the product. However, materials of headings 3003 and 3004 may be used, provided that their total value does not exceed 20 % of the ex-works price of the product, and in which the value of all the materials used does not exceed 50 % of the ex-works price of the product
Generalised Scheme of Preferences (GSP, GSP+, EBA) · Armenia, India, Kenya, Pakistan, Samoa, Solomon Islands, Syria, Vietnam
EU-Singapore FTA · Singapore

Pharmaceutical products / or: Manufacture from materials of any heading
Autonomous Trade Preferences (Western Balkans) · Kosovo

Medicaments (excluding goods of heading 3002, 3005 or 3006):
- Obtained from amikacin of heading 2941 / or: Manufacture from materials of any heading, except that of the product. However, materials of headings 3003 and 3004 may be used, provided that their total value does not exceed 20 % of the ex-works price of the product
- Other / or: Manufacture: from materials of any heading, except that of the product. However, materials of headings 3003 and 3004 may be used, provided that their total value does not exceed 20 % of the ex-works price of the product, and in which the value of all the materials used does not exceed 50 % of the ex-works price of the product
EU-Canada CETA · Canada

A change from within any one of these subheadings or any other subheading.
EU-Chile Association Agreement · Chile

Medicaments (excluding goods of heading 3002, 3005 or 3006): — Obtained from amikacin of heading 2941 / or: Manufacture from materials of any heading, except that of the product. However, materials of headings 3003 or 3004 may be used, provided that their total value does not exceed 20 % of the ex-works price of the product — Other / or: Manufacture: from materials of any heading, except that of the product. However, materials of headings 3003 or 3004 may be used, provided that their total value does not exceed 20 % of the ex-works price of the product, and in which the value of all the materials used does not exceed 50 % of the ex-works price of the product
EU-Colombia/Peru/Ecuador Trade Agreement · Colombia, Ecuador, Peru

Medicaments (excluding products of heading 3002, 3005 or 3006):
Obtained from amikacin of heading 2941 / or: Manufacture from materials of any heading, except that of the product. However, materials of headings 3003 and 3004 may be used, provided that their total value does not exceed 20 per cent of the ex-works price of the product
Other / or: Manufacture: from materials of any heading, except that of the product. However, materials of headings 3003 and 3004 may be used, provided that their total value does not exceed 20 per cent of the ex-works price of the product, and in which the value of all the materials used does not exceed 50 per cent of the ex-works price of the product
EPA CARIFORUM

Medicaments (excluding goods of heading No 3002, 3005 or 3006): – Obtained from amikacin of heading No 2941 / or: Manufacture in which all the materials used are classified within a heading other than that of the product. However, materials of heading No 3003 or 3004 may be used provided their value, taken together, does not exceed 20 % of the ex-works price of the product – Other / or: Manufacture in which: – all the materials used are classified within a heading other than that of the product. However, materials of heading No 3003 or 3004 may be used provided their value, taken together, does not exceed 20 % of the ex-works price of the product; – the value of all the materials used does not exceed 50 % of the ex-works price of the product
EPA Eastern and Southern Africa

– Obtained from amikacin of heading No 2941 / or: Manufacture in which all the materials used are classified within a heading other than that of the product. However, materials of heading No 3003 or 3004 may be used provided their value, taken together, does not exceed 20 % of the ex works price of the product
EU Market Access Regulation (EPA) · Cameroon, Côte d’Ivoire, Ghana, Kenya

Medicaments (excluding goods of heading No 3002, 3005 or 3006):
– Obtained from amikacin of heading No 2941 / or: Manufacture in which all the materials used is classified within a heading other than that of the product. However, materials of heading No 3003 or 3004 may be used provided their value, taken together, does not exceed 20 % of the ex-works price of the product
– Other / or: Manufacture in which: all the materials used are classified within a heading other than that of the product. However, materials of heading No 3003 or 3004 may be used provided their value, taken together, does not exceed 20 % of the ex-works price of the product; the value of all the materials used does not exceed 50 % of the ex-works price of the product
EPA Pacific · Fiji, Papua New Guinea, Samoa, Solomon Islands

Medicaments (excluding goods of heading No 3002, 3005 or 3006): – Obtained from amikacin of heading No 2941 / or: Manufacture in which all the materials used are classified within a heading other than that of the product. However, materials of heading No 3003 or 3004 may be used provided their value, taken together, does not exceed 20 % of the ex works price of the product
EU-Israel Association Agreement · Israel

Medicaments (excluding goods of heading Nos 3002, 3005 and 3006) / or: Manufacture in which: all the materials used are classified within a heading other than that of the product. However, materials of heading Nos 3003 or 3004 may be used provided their value, taken together, does not exceed 20 % of the ex-works price of the product, and the value of all the materials used does not exceed 50 % of the ex-works price of the product
EU-Jordan Association Agreement · Jordan

Medicaments (excluding goods of heading 3002, 3005 or 3006): - Obtained from amikacin of heading 2941 / or: Manufacture from materials of any heading, except that of the product. However, materials of headings 3003 and 3004 may be used, provided that their total value does not exceed 20 % of the ex-works price of the product - Other / or: Manufacture: from materials of any heading, except that of the product. However, materials of headings 3003 and 3004 may be used, provided that their total value does not exceed 20 % of the ex-works price of the product, and in which the value of all the materials used does not exceed 50 % of the ex-works price of the product
EU-Japan EPA · Japan

CTSH; A chemical reaction, purification, mixing and blending, production of standard materials, a change in particle size, isomer separation or biotechnological processing is undergone; MaxNOM 50 % (EXW); or RVC 55 % (FOB).
EU-Korea FTA · South Korea

Pharmaceutical products; except for: / or: Manufacture from materials of any heading, except that of the product. However, materials of the same heading as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product
EU-Central America Association Agreement

Medicaments (excluding goods of heading 3002, 3005 or 3006): / or: Manufacture from materials of any heading, except that of the product and heading 3003
EU-Lebanon Association Agreement · Lebanon

Medicaments (excluding goods of heading 3002, 3005 or 3006):
– Obtained from amikacin of heading 2941 / or: Manufacture from materials of any heading, except that of the product. However, materials of headings 3003 and 3004 may be used, provided that their total value does not exceed 20 % of the ex-works price of the product
– Other / or: Manufacture: from materials of any heading, except that of the product. However, materials of headings 3003 and 3004 may be used, provided that their total value does not exceed 20 % of the ex-works price of the product, in which the value of all the materials used does not exceed 50 % of the ex-works price of the product
EU-Mexico Global Agreement · Mexico

Medicaments (excluding goods of heading No 3002, 3005 or 3006): — Obtained from amikacin of heading No 2941 / or: Manufacture in which all the materials used are classified within a heading other than that of the product. However, materials of heading No 3003 or 3004 may be used provided their value, taken together, does not exceed 20 % of the ex-works price of the product — Other / or: Manufacture in which: all the materials used are classified within a heading other than that of the product. However, materials of heading No 3003 or 3004 may be used provided their value, taken together, does not exceed 20 % of the ex-works price of the product, the value of all the materials used does not exceed 50 % of the ex-works price of the product
EU-Palestine Interim Association Agreement · Palestine

Medicaments (excluding goods of heading No 3002, 3005 or 3006): - Obtained from amikacin of heading No 2941 - Other / or: Manufacture in which all the materials used are classified within a heading other than that of the product. However, materials of heading No 3003 or 3004 may be used provided their value, taken together, does not exceed 20 % of the ex works price of the product Manufacture in which: all the materials used are classified within a heading other than that of the product. However, materials of heading No 3003 or 3004 may be used provided their value, taken together, does not exceed 20% of the ex-works price of the product; the value of all the materials used does not exceed 50% of the ex-works price of the product
EU-Tunisia Association Agreement · Tunisia

Medicaments (excluding goods of heading 3002, 3005 or 3006): Obtained from amikacin of heading 2941 / or: Manufacture from materials of any heading, except that of the product. However, materials of headings 3003 and 3004 may be used, provided that their total value does not exceed 20 % of the ex-works price of the product Manufacture: from materials of any heading, except that of the product. However, materials of headings 3003 and 3004 may be used, provided that their total value does not exceed 20 % of the ex-works price of the product, and in which the value of all the materials used does not exceed 50 % of the ex-works price of the product
EU-Viet Nam FTA · Vietnam

Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or in forms of packing for retail sale. / or: Manufacture from materials of any heading, except that of the product; or manufacture in which the value of all the materials used does not exceed 70 % of the ex-works price of the product.

Source: European Commission, Access2Markets (CC BY 4.0, shortened). The text of the agreement prevails. Access2Markets

Legal and explanatory notes for 3004900000

3004 CN Explanatory Notes: Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale

See additional note 1 to this chapter. Unlike the previous heading, this heading covers ‘unmixed products’. For the interpretation of the term ‘unmixed products’, see note 3(a) to this chapter and the HS Explanatory Note to heading 3004, fourth and fifth paragraphs. The terms ‘in measured doses (including those in the form of transdermal administration systems)’ and ‘forms or packings for retail sale for therapeutic or prophylactic uses’ are defined in the HS Explanatory Note to heading 3004, first and second paragraphs. Medicaments put up in packings for long-term administration or for hospitals and similar establishments are included here. In this case, a larger number of units of the product is contained and the intended long-term administration or hospital use is generally indicated on the packing. The fact that medicaments containing, for example, antibiotics, hormones or lyophilised products, and put up in ampoules or bottles must still have added to them pyrogen-free water or another diluent before being administered, does not exclude them from this heading. The heading includes, inter alia, preparations containing a sufficient quantity of active substances per daily dose (e.g. hormones or co-factors) to provide therapeutic or prophylactic effects against a specific disease or ailment. The daily dose is recommended on the label, packaging or on the accompanying user directions of such products. The index of Anatomical Therapeutic Chemicals (WHO ATC-DDD index) (https://www.whocc.no/atc_ddd_index/), developed by the World Health Organisation (WHO), indicates the Defined Daily Dose (DDD) providing therapeutic or prophylactic effect when applied in quantities equal to or exceeding the amounts listed in that index. The following table shows the DDD for the substances listed: Name of the active substance | Defined Daily Dose | Unit | Administration route α-lipoic acid or thioctic acid | 0,6 | g | oral 0,6 | g | parenteral Glucosamine sulfate | 1,5 | g | oral Levocarnitine | 2 | g | oral 2 | g | parenteral Lovastatin | 45 | mg | oral Melatonin | 2 | mg | oral N-acetylcysteine | 0,5 | g | oral Yohimbine | 15 | mg | oral

Notes to chapter 30

Notes 1. This chapter does not cover: (a) foods or beverages (such as dietetic, diabetic or fortified foods, food supplements, tonic beverages and mineral waters), other than nutritional preparations for intravenous administration (Section IV); (b) products, such as tablets, chewing gum or patches (transdermal systems), containing nicotine and intended to assist tobacco use cessation (heading 2404); (c) plasters specially calcined or finely ground for use in dentistry (heading 2520); (d) aqueous distillates or aqueous solutions of essential oils, suitable for medicinal uses (heading 3301); (e) preparations of headings 3303 to 3307, even if they have therapeutic or prophylactic properties; (f) soap or other products of heading 3401 containing added medicaments; (g) preparations with a basis of plaster for use in dentistry (heading 3407); (h) blood albumin not prepared for therapeutic or prophylactic uses (heading 3502); or (ij) diagnostic reagents of heading 3822. 2. For the purposes of heading 3002, the expression ‘immunological products’ applies to peptides and proteins (other than goods of heading 2937) which are directly involved in the regulation of immunological processes, such as monoclonal antibodies (MAB), antibody fragments, antibody conjugates and antibody fragment conjugates, interleukins, interferons (IFN), chemokines and certain tumour-necrosis factors (TNF), growth factors (GF), hematopoietins and colony-stimulating factors (CSF). 3. For the purposes of headings 3003 and 3004 and of note 4(d) to this chapter, the following are to be treated: (a) as unmixed products: (1) unmixed products dissolved in water; (2) all goods of Chapter 28 or 29; and (3) simple vegetable extracts of heading 1302, merely standardised or dissolved in any solvent; (b) as products which have been mixed: (1) colloidal solutions and suspensions (other than colloidal sulphur); (2) vegetable extracts obtained by the treatment of mixtures of vegetable materials; and (3) salts and concentrates obtained by evaporating natural mineral waters. 4. Heading 3006 applies only to the following, which are to be classified in that heading and in no other heading of the nomenclature: (a) sterile surgical catgut, similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for surgical wound closure; (b) sterile laminaria and sterile laminaria tents; (c) sterile absorbable surgical or dental haemostatics; sterile surgical or dental adhesion barriers, whether or not absorbable; (d) opacifying preparations for X-ray examinations and diagnostic reagents designed to be administered to the patient, being unmixed products put up in measured doses or products consisting of two or more ingredients which have been mixed together for such uses; (e) placebos and blinded (or double-blinded) clinical trial kits for use in recognised clinical trials, put up in measured doses, even if they might contain active medicaments; (f) dental cements and other dental fillings; bone reconstruction cements; (g) first-aid boxes and kits; (h) chemical contraceptive preparations based on hormones, on other products of heading 2937 or on spermicides; (ij) gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments; (k) waste pharmaceuticals, that is, pharmaceutical products which are unfit for their original intended purpose due to, for example, expiry of shelf life; and (l) appliances identifiable for ostomy use, that is, colostomy, ileostomy and urostomy pouches cut to shape and their adhesive wafers or faceplates. Subheading notes 1. For the purposes of subheadings 3002 13 and 3002 14, the following are to be treated: (a) as unmixed products, pure products, whether or not containing impurities; (b) as products which have been mixed: (1) the products mentioned in (a) above dissolved in water or in other solvents; (2) the products mentioned in (a) and (b) (1) above with an added stabiliser necessary for their preservation or transport; and (3) The products mentioned in (a), (b) (1) and (b) (2) above with any other additive. 2. Subheadings 3003 60 and 3004 60 cover medicaments containing artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or containing any of the following active principles, whether or not combined with other pharmaceutical active ingredients : amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN). Additional note 1. Heading 3004 includes herbal medicinal preparations and preparations based on the following active substances: vitamins, minerals, essential amino-acids or fatty acids, in packings for retail sale. These preparations are classified in heading 3004 if they bear on the label, packaging or on the accompanying user directions the following statements of: (a) the specific diseases, ailments or their symptoms for which the product is to be used; (b) the concentration of active substance or substances contained therein; (c) dosage; and (d) mode of application. This heading includes homeopathic medicinal preparations when they meet the conditions of (a), (c) and (d) mentioned above. In the case of preparations based on vitamins, minerals, essential amino-acids or fatty acids, the level of one of these substances per recommended daily dose indicated on the label must be significantly higher than the recommended daily allowance to maintain general health or well-being.

Other explanatory notes for the chapter

Additional note 1 1. Herbal medicinal preparations are preparations based on one or more active substances, produced by subjecting a plant or parts thereof to a process such as drying, crushing, extraction or purification. Active substance means a chemically defined substance, a chemically defined group of substances (for example, alkaloids, polyphenols, anthocyanins) or a plant extract. These active substances must have medicinal properties for the prevention or the treatment of specific diseases, ailments or their symptoms. 2. Homeopathic medicinal preparations are prepared from products, substances or compositions called homeopathic stocks (mother tinctures). The degree of dilution must be indicated (for example, D6). 3. Vitamins or mineral preparations are preparations based on vitamins of heading 2936, on minerals including trace elements and mixtures thereof. They are used to treat or prevent specific diseases, ailments or their symptoms. Such preparations contain a much higher amount of vitamins or minerals, generally at least three times higher than the recommended daily allowance (RDA). As regards the recommended daily allowance (RDA) for certain vitamins and minerals, see, for example, the table in the Annex XIII to Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 October 2011 on the provision of food information to consumers (OJ L 304, 22.11.2011, p. 58) reproduced below: Vitamins and minerals | RDA Vitamin A | 800 μg Vitamin D | 5 μg Vitamin E | 12 mg Vitamin K | 75 μg Vitamin C | 80 mg Thiamin 1,1 mg Riboflavin | 1,4 mg Niacin 16 mg Vitamin B6 | 1,4 mg Folic acid | 200 μg Vitamin B12 | 2,5 μg Biotin 50 μg Pantothenic acid | 6 mg Potassium | 2 000 mg Chloride 800 mg Calcium 800 mg Phosphorus | 700 mg Magnesium | 375 mg Iron 14 mg Zinc 10 mg Copper 1 mg Manganese | 2 mg Fluoride 3,5 mg Selenium 55 μg Chromium 40 μg Molybdenum | 50 μg Iodine 150 μg 4. Recommended daily allowance (RDA) for adults with a weight of 70 kg, on essential amino acids, according to the joint WHO/FAO/UNU expert Consultation 2007: Essential Amino Acid | RDA (mg) Histidine | 700 Isoleucine | 1 400 Leucine 2 730 Lysine 2 100 Methionine + Cysteine | 1 050 Cysteine 287 Methionine | 728 Phenylalanine + Tyrosine | 1 750 Threonine | 1 050 Tryptophan | 280 Valine 1 820 Recommended daily allowance (RDA) for adults with a weight of 70 kg, on essential fatty acids, according to the joint WHO/FAO/UNU expert Consultation 2007. Types of essential fatty acids | Name of essential fatty acid | RDA (g) n-3 polyunsaturated fatty acids | linolenic acid (ALA) | 2 long-chain n-3 polyunsaturated fatty acids | EPA plus DHA | 0,25 n-6 polyunsaturated fatty acids | linoleic acid | 10

Sources: Combined Nomenclature 2026, Annex I to Regulation (EEC) No 2658/87 (CELEX 32025R1926), and the Explanatory Notes to the Combined Nomenclature (CELEX 02019XC0329(02)-20260213). The section and chapter notes are legally binding; the explanatory notes are guidance. EUR-Lex

EU classification regulations for 3004900000

Commission regulations that classified specific goods under this code. They bind customs in every member state for identical goods.

3004 90 00 Jun 8, 2016 · Regulation on EUR-Lex

A product put up for retail sale in gelatine capsules, one capsule consisting of (mg):

— simethicone: 257,5 — gelatine, glycerol, dimethicone, titanium dioxide (E 171), potassium sorbate, food colourants E 110 and E 122: approx. 196 The product soothes stomach pain and prevents bloating and flatulence. According to its label, the product is presented for human consumption with a recommended daily dose of one to two capsules after each main meal of the day.

Reasons

Classification is determined by the general rules 1 and 6 for the interpretation of the Combined Nomenclature, Note 1(f) to Chapter 21 and the wording of CN codes 3004 and 3004 90 00 . The product, due to the presence of simethicone, has therapeutic properties. Its classification under heading 2106 as a food preparation not elsewhere specified or included is therefore excluded (see Note 1(f) to Chapter 21). The product is put up for retail sale in measured doses and exhibits clearly defined prophylactic or therapeutic properties, e.g. against functional dyspepsia. The product is therefore to be classified as a medicament put up in measured doses for retail sale in CN code 3004 90 00 .
3004 90 00 Nov 28, 2013 · Regulation on EUR-Lex

The product is put up for retail sale in tablet form with a total weight of ca. 900 mg each, one tablet consisting of (mg):

— alpha-lipoic acid 300, — calcium (as dibasic calcium phosphate) 88,5, — microcrystalline cellulose, hydroxypropyl ethylcellulose, colloidal silicon dioxide and magnesium stearate ca. 511. According to the label, the product is presented as a food supplement for human consumption. The recommended daily dose indicated on the label is one tablet per day.

Reasons

Classification is determined by the General Rules 1 and 6 for the interpretation of the Combined Nomenclature and the wording of CN codes 3004 and 3004 90 00 . Although the product is presented as a food supplement, it has effects in the field of the prevention or treatment of diseases or ailments. Its classification under heading 2106 as a food preparation not elsewhere specified or included is therefore excluded (see also Harmonized System Explanatory Notes to heading 2106 , point (16)). The product is put up for retail sale in measured doses and exhibits clearly defined prophylactic or therapeutic properties, e.g. against polyneuropathy. It is therefore to be classified as a medicament put up in measured doses for retail sale of heading 3004 .

UK advance tariff rulings for 3004900000

Rulings of HM Revenue & Customs for goods with UK commodity codes that start like this EU code. The UK tariff differs from the EU tariff, so these rulings are guidance for the EU.

UK 3004900000 Valid Dec 5, 2023 to Dec 4, 2026 · Ruling 600009155 on GOV.UK

Biofreeze Pain Relieving Gel Ingredients: Isopropyl Alcohol, Water, Herbal Extract (IIex paraguariensis), Carbomer, Triethanolamine, Menthol, Camphor, Silicon Dioxide, Methylparaben, Glycerine, Propylene Glycol, FD&C yellow #5, FD&C blue #1 For the temporary relief of minor aches and pains of muscles and joints associated with arthritis pain, backache, strains and sprains. Packaging: 112gr/118ml tube

Justification

Classification has been determined in accordance with the following:- For the purposes of determining the commodity codes within which goods most appropriately fall, reg 3 (1) of The Customs Tariff (Establishment) (EU Exit) Regulations 2020 sets out that the rules of interpretation contained in the following have effect – a. Part Two (Goods Classification Table Rules of Interpretation) of the Tariff of the United Kingdom (Reg 3(1)(a)); and b. Notes to a section or chapter of the Goods Classification Table (Reg 3(1)(b)). General Interpretative Rules (GIR)s GIR 1 has been used to classify this product by the terms of heading 3004 - Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale GIR 5b has been used to identify the type of packaging – 112gr/118ml tube GIR 6 has been used to classify the goods to subheading level 300490 – Other than elsewhere specified Also classified in accordance with: Chapter 30 additional note 1 Section note 2 HSEN to 3004
UK 3004900000 Valid Dec 5, 2023 to Dec 4, 2026 · Ruling 600009181 on GOV.UK

Biofreeze Pain Relieving Gel roll-on Ingredients: Isopropyl Alcohol, Water, Herbal Extract (IIexparaguariensis),Carbomer, Triethanolamine, Menthol, Camphor, Silicon Dioxide, Methylparaben, Glycerine, Propylene Glycol, FD&C yellow #5,FD&C blue #1 For the temporary relief of minor aches and pains of muscles and joints associated with arthritis pain, backache, strains and sprains Packaging: 84gr/89ml

Justification

Classification has been determined in accordance with the following:- For the purposes of determining the commodity codes within which goods most appropriately fall, reg 3 (1) of The Customs Tariff (Establishment) (EU Exit) Regulations 2020 sets out that the rules of interpretation contained in the following have effect – a. Part Two (Goods Classification Table Rules of Interpretation) of the Tariff of the United Kingdom (Reg 3(1)(a)); and b. Notes to a section or chapter of the Goods Classification Table (Reg 3(1)(b)). General Interpretative Rules (GIR)s GIR 1 has been used to classify this product by the terms of heading 3004 - Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale GIR 5b has been used to identify the type of packaging – 84gr/89ml GIR 6 has been used to classify the goods to subheading level 300490 – Other than elsewhere specified Also classified in accordance with: Chapter 30 additional note 1 Section note 2 HSEN to 3004
UK 3004900000 Valid Dec 5, 2023 to Dec 4, 2026 · Ruling 600009182 on GOV.UK

Biofreeze Spray Ingredients: Ethanol, Arnica Montana, Calendula, Chamomile, DimethylSulfone, Echinacea, Menthol, Ilex Paraguariensis, IsopropylMyristate, Juniper Berry, Purified Water USP, White Tea For the temporary relief of minor aches and pains of muscles and joints associated with arthritis pain, backache, strains and sprains Packaging: 104gr/118ml

Justification

Classification has been determined in accordance with the following:- For the purposes of determining the commodity codes within which goods most appropriately fall, reg 3 (1) of The Customs Tariff (Establishment) (EU Exit) Regulations 2020 sets out that the rules of interpretation contained in the following have effect – a. Part Two (Goods Classification Table Rules of Interpretation) of the Tariff of the United Kingdom (Reg 3(1)(a)); and b. Notes to a section or chapter of the Goods Classification Table (Reg 3(1)(b)). General Interpretative Rules (GIR)s GIR 1 has been used to classify this product by the terms of heading 3004 - Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale GIR 5b has been used to identify the type of packaging – 104gr/118ml GIR 6 has been used to classify the goods to subheading level 300490 – Other than elsewhere specified Also classified in accordance with: Chapter 30 additional note 1 Section note 2 HSEN to 3004

+ 10 more

UK 3004900000 Valid Jul 19, 2024 to Jul 18, 2027 · Ruling 600010435 on GOV.UK

The product is infant drops which is used to break down most of the lactose in breast milk or infant formula, making it easier to digest. Recommended use is 4 drops per a feed. It is packaged into vials of 7ml, application of nozzle and cap. The cap is tamper proof, for added safety with a seal to the cap. It is placed into a carton with insert, outer cardboard box, with an instruction leaflet, sealed in packs of 6. Ingredients: Glycerol, Aqueous Neutral B- galactosidase, (lactase enzyme), potassium chloride.

Justification

Classification has been determined in accordance with the following: For the purposes of determining the commodity codes within which goods most appropriately fall, Reg 3 (1) of The Customs Tariff (Establishment) (EU Exit) Regulations 2020 sets out that the rules of interpretation contained in the following have effect – a. Part Two (Goods Classification Table Rules of Interpretation) of the Tariff of the United Kingdom (Reg 3(1)(a); and b. Notes to a section or chapter of the Goods Classification Table (Reg 3(1)(b) - General Interpretative Rules (GIR)s General Interpretative Rules (GIR)S: GIR 1 - Has been used to classify this product by the terms of the heading 3004 - medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale GIR 5b - has been used to identify the type of packaging - Vial of 7ml with a nozzle and cap placed into a carton with insert, outer cardboard box. GIR 6 - Has been used to classify the goods to subheading 300490 - other than elsewhere …
UK 3004900000 Valid Oct 3, 2024 to Oct 2, 2027 · Ruling 600011307 on GOV.UK

Lubricating Eye Drops. Consists of a dropper bottle in a sealed pouch. This is a formulation which targets dry spots which appear on the surface of the eye. It restores and lubricates the natural tear film, for long-lasting relief and protection from dry eye symptoms. Ingredients: Propylene Glycol, Povidone, Boric Acid, Sodium Borate, Menthol, Calcium Chloride, Magnesium Sulphate, Polyoxyl Stearate, Polyoxyethylene Castor Oil, Poloxamer, Edetate Disodium, Sesame Oil, Polyhexamethylene Biguanide, Purified Water. Put up for retail sale in a 10ml PET plastic bottle.

Justification

Classification Has Been Determined In Accordance With The Following: For the purposes of determining the commodity codes within which goods most appropriately fall, reg 3(1) of The Customs Tariff (Establishment) (EU Exit) Regulations 2020 sets out that the rules of interpretation contained in the following have effect - a. Part Two (Goods Classification Table Rules of Interpretation) of the Tariff of the United Kingdom (Reg 3(1)(a)); and b. Notes to a section or chapter of the goods Classification Table (Reg 3(1)(b)). General Interpretative Rules (GIR)S: GIR 1 has been used to classify this product by the terms of heading 3004 medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. GIR 5B has been used to identify the type of packaging: a 10ml PET plastic bottle. GIR 6 has been used to classify the goods to subheading level 300490 – other than elsewhere specified or included. Also classified in accordance with: HSENS to heading 3004.
UK 3004900000 Valid Oct 3, 2024 to Oct 2, 2027 · Ruling 600011308 on GOV.UK

Lubricating Eye Drops – Consists of a dropper bottle in a sealed pouch. A formulation to target dry spots which appear on the surface of the eye. It restores and lubricates the natural tear film, for long-lasting relief and protection from tired, dry eye symptoms. Ingredients: Propylene Glycol, Povidone, Boric Acid, Sodium Borate, Menthol, Calcium Chloride, Magnesium Sulphate, Polyoxyl Stearate, Polyoxyethylene Castor Oil, Poloxamer, Edetate Disodium, Sesame Oil, Polyhexamethylene Biguanide, Purified Water. Put up for retail sale in a 10ml PET plastic bottle.

Justification

Classification Has Been Determined In Accordance With The Following: For the purposes of determining the commodity codes within which goods most appropriately fall, reg 3(1) of The Customs Tariff (Establishment) (EU Exit) Regulations 2020 sets out that the rules of interpretation contained in the following have effect - a. Part Two (Goods Classification Table Rules of Interpretation) of the Tariff of the United Kingdom (Reg 3(1)(a)); and b. Notes to a section or chapter of the goods Classification Table (Reg 3(1)(b)). General Interpretative Rules (GIR)S: GIR 1 has been used to classify this product by the terms of heading 3004 medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. GIR 5B has been used to identify the type of packaging: a 10ml PET plastic bottle. GIR 6 has been used to classify the goods to subheading level 300490 – other than elsewhere specified or included. Also classified in accordance with: HSENS to heading 3004.
UK 3004900000 Valid Nov 1, 2024 to Oct 31, 2027 · Ruling 600011661 on GOV.UK

A prescription pharmaceutical preparation Contains: omeprazole, sodium carbonate & sodium bicarbonate Mechanism of action: proton pump inhibitor Use: treatment of gastroesophageal reflux, peptic ulcers & Zollinger- Ellison syndrome Packaged as a carton containing a bottle of omeprazole powder 100ml, together with a bottle of water diluent

Justification

Classification has been determined in accordance with the following:- For the purposes of determining the commodity codes within which goods most appropriately fall, reg 3 (1) of The Customs Tariff (Establishment) (EU Exit) Regulations 2020 sets out that the rules of interpretation contained in the following have effect – a. Part Two (Goods Classification Table Rules of Interpretation) of the Tariff of the United Kingdom (Reg 3(1)(a)); and b. Notes to a section or chapter of the Goods Classification Table (Reg 3(1)(b)). General Interpretative Rules (GIR)s GIR 1 has been used to classify this product by the terms of heading 3004 - Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale GIR 5b has been used to identify the type of packaging – a carton containing a bottle of omeprazole powder together with a bottle of water diluent GIR 6 has been used to classify the goods to subheading level 300490 – Other than elsewhere specified Also classified in accordance …
UK 3004900000 Valid May 2, 2025 to May 1, 2028 · Ruling 600012665 on GOV.UK

Submucosal Lifting Agent used in endoscopic procedures to create a cushion-like space between the mucosa and underlining tissue Single use

Justification

Classification has been determined in accordance with the following:- For the purposes of determining the commodity codes within which goods most appropriately fall, reg 3 (1) of The Customs Tariff (Establishment) (EU Exit) Regulations 2020 sets out that the rules of interpretation contained in the following have effect – a. Part Two (Goods Classification Table Rules of Interpretation) of the Tariff of the United Kingdom (Reg 3(1)(a)); and b. Notes to a section or chapter of the Goods Classification Table (Reg 3(1)(b)). General Interpretative Rules (GIR)s GIR 1 has been used to classify this product by the terms of heading 3004 - Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale GIR 6 has been used to classify the goods to subheading level 300490 – Other than elsewhere specified Also classified in accordance with: Additional chapter note 1 Section note 2 WCO opinions to 300490
UK 3004900000 Valid Sep 3, 2025 to Sep 2, 2028 · Ruling 600013517 on GOV.UK

radiopharmaceutical containing the radioactive isotope Lutetium-177 single patient dose, administered intravenously, via the vial Physical form: liquid Use: in clinical trials for assessment of its performance as a therapeutic medicine in humans Packaging :a vial held within shielded container to give protection against the radioactivity

Justification

Classification has been determined in accordance with the following:- For the purposes of determining the commodity codes within which goods most appropriately fall, reg 3 (1) of The Customs Tariff (Establishment) (EU Exit) Regulations 2020 sets out that the rules of interpretation contained in the following have effect – a. Part Two (Goods Classification Table Rules of Interpretation) of the Tariff of the United Kingdom (Reg 3(1)(a)); and b. Notes to a section or chapter of the Goods Classification Table (Reg 3(1)(b)). General Interpretative Rules (GIR)s GIR 1 has been used to classify this product by the terms of heading 3004 - Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale GIR 5b has been used to identify the type of packaging – a vial held within shielded container to give protection against the radioactivity GIR 6 has been used to classify the goods to subheading level 300490 – Other than elsewhere specified Also classified in accordance with: HSEN …
UK 3004900000 Valid Sep 3, 2025 to Sep 2, 2028 · Ruling 600013518 on GOV.UK

Radiopharmaceutical containing the radioactive isotope Actinium-225. single patient dose, administered intravenously, via the vial Physical form: a liquid Used in clinical trials for assessment of its performance as a therapeutic medicine in humans Packaging: single use vial

Justification

Classification has been determined in accordance with the following:- For the purposes of determining the commodity codes within which goods most appropriately fall, reg 3 (1) of The Customs Tariff (Establishment) (EU Exit) Regulations 2020 sets out that the rules of interpretation contained in the following have effect – a. Part Two (Goods Classification Table Rules of Interpretation) of the Tariff of the United Kingdom (Reg 3(1)(a)); and b. Notes to a section or chapter of the Goods Classification Table (Reg 3(1)(b)). General Interpretative Rules (GIR)s GIR 1 has been used to classify this product by the terms of heading 3004 - Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale GIR 5b has been used to identify the type of packaging – a vial held within shielded container to give protection against the radioactivity GIR 6 has been used to classify the goods to subheading level 300490 – Other than elsewhere specified Also classified in accordance with: HSEN …
UK 3004900000 Valid Sep 16, 2026 to Sep 15, 2029 · Ruling 600015874 on GOV.UK

A sterile physiological saline solution Used as an extraocular and intraocular irrigation solution in eye surgery Presented in a plastic bottle with a capacity of 15 ml, and in glass bottles or flexible plastic bags with a capacity of 250 or 500 ml

Justification

Classification Has Been Determined In Accordance With The Following: For the purposes of determining the commodity codes within which goods most appropriately fall, reg 3(1) of The Customs Tariff (Establishment) (EU Exit) Regulations 2020 sets out that the rules of interpretation contained in the following have effect - a. Part Two (Goods Classification Table Rules of Interpretation) of the Tariff of the United Kingdom (Reg 3(1)(a)); and b. Notes to a section or chapter of the goods Classification Table (Reg 3(1)(b)). General Interpretative Rules (GIR)S: GIR 1 has been used to classify this product by the terms of heading 3004 medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. GIR 5B has been used to identify the type of packaging: presented in a plastic bottle with a capacity of 15 ml, and in glass bottles or flexible plastic bags with a capacity of 250 or 500 ml GIR 6 has been used to classify the goods to subheading level 300490 – other than elsewhere …
UK 3004900000 Valid Sep 1, 2026 to Aug 31, 2029 · Ruling 600015890 on GOV.UK

Formoline L112 tablets to support weight management and reduction of dietary fat absorption and lowering of LDL cholesterol active component is polyglucosamine, also contain excipients used in tablet manufacture, including binders, fillers and coating materials packed in boxes of 64 tablets, with foil and plastic cards and and IFU sheet, 88 inner cartons per shipping case

Justification

Classification has been determined in accordance with the following:- For the purposes of determining the commodity codes within which goods most appropriately fall, reg 3 (1) of The Customs Tariff (Establishment) (EU Exit) Regulations 2020 sets out that the rules of interpretation contained in the following have effect : a. Part Two (Goods Classification Table Rules of Interpretation) of the Tariff of the United Kingdom (Reg 3(1)(a)); and b. Notes to a section or chapter of the Goods Classification Table (Reg 3(1)(b)) General Interpretative Rules (GIR)s: GIR 1 - Has been used to classify this product by the terms of heading 3004 - Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. GIR 5 B - Has been used to identify the type of packaging - packed in boxes of 64 tablets, with foil and plastic cards and and IFU sheet, 88 inner cartons per shipping case. GIR 6 - Has been used to classify the goods to subheading level 300490 - Other than elsewhere specified. …
UK 3004900000 Valid Sep 8, 2026 to Sep 7, 2029 · Ruling 600016281 on GOV.UK

A sterile inhalation saline solution intended to mobilise secretions in the respiratory tract caused by respiratory diseases. The solution contains 3% sodium chloride and is free from preservatives. It is packaged in 20 × 4 ml ampoules for use with a jet, membrane, or ultrasonic nebuliser.

Justification

Classification has been determined in accordance with the following: For the purposes of determining the commodity codes within which goods most appropriately fall, reg 3 (1) of The Customs Tariff (Establishment) (EU Exit) Regulations 2020 sets out that the rules of interpretation contained in the following have effect – a. Part Two (Goods Classification Table Rules of Interpretation) of the Tariff of the United Kingdom (Reg 3(1)(a)); and b. Notes to a section or chapter of the Goods Classification Table (Reg 3(1)(b)) General Interpretative Rules (GIR)s: GIR 1 Has been used to classify this product by the terms of heading 3004 - Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. GIR 5B Has been used identify the type of packaging: 4 ml ampoules. GIR 6 Has been used to classify this product by the terms of heading 300490 - Other than elsewhere specified. Also classified in accordance with: Harmonised System Explanatory Notes to heading 3004

Source: HM Revenue & Customs, Advance Tariff Rulings. Contains public sector information licensed under the Open Government Licence v3.0.

EU trade in 2025 for 300490

Extra-EU imports: €43.7B; 228,170 t
Extra-EU exports: €131.2B

Top origin countries by import value

Switzerland €16.9B
United States €14B
United Kingdom €5.4B
India €2B
Canada €1.3B

CN8 codes below this code: 1. Source: Eurostat, Comext, CC BY 4.0, processed by hscode.info. Confidential trade is not allocated to codes.

HS 2028 change

This subheading changes on 1 January 2028.

HS 2022 subheading 300490 is split. New HS 2028 subheadings: 300479, 300490.

From the WCO HS 2022 to HS 2028 correlation tables, a guide only. The EU sets its own CN codes for 2028.

UK import duty for 300490

Third-country duties of all UK commodity codes under this HS subheading. Source: UK Department for Business and Trade, as of Nov 2, 2026. The UK tariff differs from the EU tariff.

Import VAT in the EU

Austria 20 %
Belgium 21 % maybe 6 %
Bulgaria 20 %
Croatia 25 % maybe 5 %
Cyprus 19 % maybe 5 %
Czechia 21 % maybe 12 %
Denmark 25 %
Estonia 24 % maybe 9 %
Finland 25.5 % maybe 13.5 %
France 20 % maybe 2.1 %, 10 %
Germany 19 %
Greece 24 % maybe 6 %, 13 %
Hungary 27 %
Ireland 23 %
Italy 22 % maybe 10 %
Latvia 21 % maybe 12 %
Lithuania 21 % maybe 5 %
Luxembourg 17 % maybe 3 %
Malta 18 %
Netherlands 21 % maybe 9 %
Poland 23 %
Portugal 23 % maybe 6 %
Romania 21 % maybe 11 %
Slovakia 23 % maybe 5 %
Slovenia 22 % maybe 9.5 %
Spain 21 %
Sweden 25 %

Standard rate per member state, on the customs value, the duty and transport to the destination. Reduced rates often depend on the use or the buyer and apply only where the country provides them for these goods. Source: European Commission, Taxes in Europe Database, as of Nov 2, 2026.

Rules of origin

Preferential rules of origin for subheading 300490 depend on the trade agreement. The Commission publishes them in Access2Markets.

Rules of origin on Access2Markets

Information

When importing or exporting "Other", it is crucial to have the correct HS code or TARIC code. The HS code 3004900000 80 serves as the standard code for this product, ensuring that the appropriate duties and taxes are applied when crossing international borders.

To ensure your business transactions run smoothly when importing or exporting "Other", consider the following points:

Inform yourself about the specific import and export regulations in the countries involved. This includes possible restrictions, taxes, and duties applicable to "Other".
Check if any additional licenses, permits, or certificates are required to import "Other" into the destination country or export it from the country of origin.
Make sure your trading partners have valid identification numbers, such as EORI numbers (Economic Operators Registration and Identification) in the EU, to streamline trade and minimize delays.
Ensure that all trade- and customs-related documents (such as commercial invoices, packing lists, certificates of origin, and insurance policies) are accurately completed and adhere to the respective national regulations.
Keep an eye on the current exchange rates, as well as packaging, shipping, and insurance costs, to accurately calculate trade costs.

In summary, the HS code or TARIC code for "Other" is 3004900000 80. Make sure you accurately use this code in all your trade and customs documents to guarantee smooth and hassle-free transactions. With these tips, you'll be better prepared for the challenges of international trade and can successfully import and export "Other".

HS Code structure

1. Chapter

There are 21 different sections, which are divided into 96 chapters. Exceptional chapters include chapter 77, which is reserved for future use, chapters 98 and 99, which are limited at national level, and chapter 99, which is a specific code for temporary changes. In the example above, chapter 30 was selected for pharmaceutical products

2. Heading

The heading determines the specific category within a certain chapter. In the example above, the 04 refers to Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale.

3. Subheading

The last two digits of the international harmonized code are more specific and define subcategories of products. In the example above, the 90 refers to Other.

HS Code tree structure

3000000000 80

Chapter PHARMACEUTICAL PRODUCTS

3004000000 80

Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale

3004100000 80

- Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives

3004200000 80

- Other, containing antibiotics

3004310000 10

- Other, containing hormones or other products of heading 2937

3004310000 80

- - Containing insulin

3004320000 80

- - Containing corticosteroid hormones, their derivatives or structural analogues

3004390000 80

- - Other

3004410000 10

- Other, containing alkaloids or derivatives thereof

3004410000 80

- - Containing ephedrine or its salts

3004420000 80

- - Containing pseudoephedrine (INN) or its salts

3004430000 80

- - Containing norephedrine or its salts

3004490000 80